Abstract
It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy (SBRT) for lung oligometastases. A systematic review of literature with a priori selection criteria was conducted on articles on the treatment of pulmonary metastases with surgery or SBRT. Only original articles with a population of patients of more than 50 were selected. After final selection, 61 articles on surgical treatment and 18 on SBRT were included. No difference was encountered in short-term survival between pulmonary metastasectomy and SBRT. In the long-term surgery seems to guarantee better survival rates. Mortality and morbidity after treatment are 0-4.7% and 0-23% for surgery, and 0-2% and 4-31% for SBRT. Surgical metastasectomy remains the treatment of choice for pulmonary oligometastases.
Lay abstract Patients with metastatic cancer with a limited number of deposits may benefit from surgical removal or irradiation of tumor nodules in addiction to chemotherapy. Surgical resection has been demonstrated to improve survival and, in some cases, can be curative. Stereotactic radiotherapy is emerging as a less invasive alternative to surgery, but settings and implications of the two treatments are profoundly different. The two techniques show similar results in the short-term, with lower complications rates for radiotherapy, while in the long-term surgery seems to guarantee higher survival rates.
Original language | English |
---|---|
Article number | FSO471 |
Number of pages | 20 |
Journal | Future Science OA |
Volume | 6 |
Issue number | 5 |
DOIs | |
Publication status | Published - Jun 2020 |
Keywords
- lung
- oligometastases
- oligorecurrence
- radiotherapy
- surgery
- CANCER LUNG METASTASES
- OLIGO-RECURRENCE
- PROGNOSTIC-FACTORS
- ASSISTED THORACOSCOPIC SURGERY
- LONG-TERM SURVIVAL
- BODY RADIATION-THERAPY
- RENAL-CELL CARCINOMA
- POSITRON-EMISSION-TOMOGRAPHY
- COLORECTAL-CANCER
- SOFT-TISSUE SARCOMA